European Innovation Council logo

European Innovation Council

Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels

Description

The European Innovation Council (EIC) is a flagship initiative of the European Union, established under the Horizon Europe program, the EU's key funding program for research and innovation. Its primary mission is to identify, develop, and scale up breakthrough technologies and disruptive innovations, particularly those originating from deep tech research. The EIC aims to support top-class innovators, entrepreneurs, and small and medium-sized enterprises (SMEs) with high-potential ideas, helping them navigate the journey from early-stage research to market-ready solutions. It plays a crucial role in strengthening Europe's innovation ecosystem and fostering global competitiveness.

The EIC operates through three main funding instruments: the EIC Pathfinder, EIC Transition, and EIC Accelerator. The EIC Pathfinder supports early-stage research and development (TRL 1-4) for breakthrough technologies, typically providing grants up to €4 million. The EIC Transition bridges the gap between research results and market opportunities (TRL 4-6), offering grants up to €2.5 million. The most relevant instrument for direct company investment is the EIC Accelerator, which targets individual SMEs, including startups and spin-outs, to develop and scale up high-risk, high-impact innovations (TRL 5/6 to 9). This program uniquely offers "blended finance," combining a grant component of up to €2.5 million with an equity investment managed by the EIC Fund.

The EIC Fund's equity investments range from €0.5 million to €15 million, providing crucial capital for scale-up activities, market penetration, and other significant costs. Since its launch in 2021 under Horizon Europe, the EIC has committed over €2.5 billion in funding, supporting more than 500 deep tech companies and 330 research projects. The EIC's strategic focus is on innovations that can create new markets or disrupt existing ones, addressing global challenges and contributing to the EU's strategic autonomy. Through its comprehensive support, the EIC seeks to transform scientific discoveries into commercially viable products and services, driving economic growth and job creation across Europe.

Investor Profile

European Innovation Council has backed more than 1,164 startups, with 58 new investments in the last 12 months alone. The firm has led 848 rounds, about 73% of its total and boasts 29 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Grant, Series Unknown, Seed rounds (top funding stages).
  • Majority of deals are located in France, Germany, The Netherlands.
  • Strong thematic focus on Health Care, Biotechnology, Medical Device.
  • Led 23 rounds in the past year.
  • Typical check size: $540K – $16.2M.

Stage Focus

  • Grant (56%)
  • Series Unknown (23%)
  • Seed (7%)
  • Series A (6%)
  • Series B (3%)
  • Convertible Note (2%)
  • Pre Seed (2%)
  • Series C (1%)

Country Focus

  • France (17%)
  • Germany (11%)
  • The Netherlands (9%)
  • Spain (8%)
  • Israel (7%)
  • Finland (6%)
  • Switzerland (6%)
  • Sweden (6%)
  • Norway (4%)
  • Ireland (3%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical Device
  • Manufacturing
  • Medical
  • Software
  • Information Technology
  • Artificial Intelligence (Ai)
  • Renewable Energy
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does European Innovation Council frequently co-invest with?

EASME - EU Executive Agency for SMEs
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 5
Invest-NL
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 6
European Commission
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 5
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 8
LIFTT
Europe, Piemonte, Italy, Turin
Co-Investments: 5
Quantonation
Europe, Ile-de-France, France, Paris
Co-Investments: 9
H2
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 7
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 12
CDP Venture Capital
Europe, Lazio, Italy, Rome
Co-Investments: 5
Co-Investments: 6

Which angels does European Innovation Council often collaborate with?

RS
North America, New York, United States, New York
Shared Deals: 1
AP
North America, California, United States, Emeryville
Shared Deals: 1
DR
Europe, England, United Kingdom, London
Shared Deals: 1
CR
Europe, Geneve, Switzerland, Geneva
Shared Deals: 1
Shared Deals: 1
MA
Europe, United Kingdom
Shared Deals: 1
MK
Europe, Zurich, Switzerland, Winterthur
Shared Deals: 1
AW
North America, New York, United States, New York
Shared Deals: 1
MI
Europe, Southern Finland, Finland, Helsinki
Shared Deals: 1
DH
Europe, Gullbringusysla, Iceland, Reykjavík
Shared Deals: 1

What are some of recent deals done by European Innovation Council?

DePoly

Sion, Valais, Switzerland

DePoly is a PET-to-raw-material recycling company that converts dirty, post-consumer plastic items into valuable raw materials.

ChemicalRecyclingWaste Management
GrantFeb 25, 2026
Step Pharma

Paris, Ile-de-France, France

Step Pharma is a biotechnology company.

BiotechnologyPharmaceutical
GrantFeb 19, 2026
Amount Raised: $2,946,897
HeyCharge

Munich, Bayern, Germany

HeyCharge provides charging infrastructure, payment systems, and installation for electric vehicles.

Charging InfrastructureElectric VehicleEnergyGreen BuildingGreenTechTransportation
GrantFeb 18, 2026
Amount Raised: $2,960,801
CubaseBio

Stockholm, Stockholms Lan, Sweden

Cubase Bio is a biotechnology business that focuses on spatial biology tools.

BiotechnologyMedical
GrantFeb 17, 2026
Amount Raised: $2,368,341
Beactica Therapeutics AB

Uppsala, Uppsala Lan, Sweden

Beactica Therapeutics is a precision oncology company developing novel small molecule therapeutics to treat genetically defined cancers.

Health CareMedicalOncology
GrantFeb 17, 2026
Amount Raised: $2,960,426
60Nd

Madrid, Madrid, Spain

60Nd is a revolutionary technology used by bio and pharma researchers for in vitro mechanical simulation of cells and bio tissues.

BiopharmaBiotechnologyLife Science
GrantFeb 10, 2026
Amount Raised: $2,853,240
equal1

San Carlos, California, United States

equal1 is a hardware development laboratories company.

ComputerHardwareManufacturingQuantum ComputingSemiconductor
Series UnknownJan 15, 2026
Amount Raised: $60,000,000
Oxcia

Stockholm, Stockholms Lan, Sweden

Oxcia is a biopharmaceutical company that provides therapies and DNA damage response mechanisms to treat cancer and inflammatory diseases.

Health CarePharmaceuticalTherapeutics
GrantDec 29, 2025
Amount Raised: $2,942,201
PlusVitech

Sevilla, Andalucia, Spain

PlusVitech develops effective and safe therapeutic treatments and complementary diagnostic tests for cancer patients.

BiotechnologyHealth CareTherapeutics
GrantDec 17, 2025
Amount Raised: $587,099
AlzeCure Pharma AB

Stockholm, Stockholms Lan, Sweden

The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD.

Pharmaceutical
GrantDec 3, 2025
Amount Raised: $2,914,531

Find More Investors Like European Innovation Council

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides